Hartford Financial Management Inc. raised its stake in shares of Shire PLC (NASDAQ:SHPG) by 5.4% during the second quarter, Holdings Channel reports. The firm owned 621 shares of the biopharmaceutical company’s stock after buying an additional 32 shares during the period. Hartford Financial Management Inc.’s holdings in Shire PLC were worth $102,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Shire PLC by 0.9% in the first quarter. Vanguard Group Inc. now owns 1,542,634 shares of the biopharmaceutical company’s stock valued at $268,773,000 after buying an additional 13,665 shares during the period. BlackRock Inc. boosted its stake in Shire PLC by 4,217.7% in the first quarter. BlackRock Inc. now owns 1,433,475 shares of the biopharmaceutical company’s stock valued at $249,755,000 after buying an additional 1,400,275 shares during the period. Janus Capital Management LLC boosted its stake in Shire PLC by 10.7% in the first quarter. Janus Capital Management LLC now owns 1,365,226 shares of the biopharmaceutical company’s stock valued at $237,854,000 after buying an additional 132,446 shares during the period. Boston Partners boosted its stake in Shire PLC by 80.7% in the first quarter. Boston Partners now owns 1,359,151 shares of the biopharmaceutical company’s stock valued at $236,805,000 after buying an additional 606,814 shares during the period. Finally, Bank of America Corp DE boosted its stake in Shire PLC by 19.7% in the first quarter. Bank of America Corp DE now owns 1,326,114 shares of the biopharmaceutical company’s stock valued at $231,049,000 after buying an additional 218,291 shares during the period. Institutional investors own 21.05% of the company’s stock.
Shares of Shire PLC (NASDAQ SHPG) opened at 167.54 on Tuesday. Shire PLC has a one year low of $158.54 and a one year high of $209.22.
Shire PLC (NASDAQ:SHPG) last announced its quarterly earnings data on Tuesday, May 2nd. The biopharmaceutical company reported $3.63 EPS for the quarter, topping analysts’ consensus estimates of $3.22 by $0.41. Shire PLC had a return on equity of 13.05% and a net margin of 2.14%. The business had revenue of $3.57 billion during the quarter. During the same period last year, the firm earned $2.12 earnings per share. The firm’s revenue for the quarter was up 109.0% on a year-over-year basis. Equities research analysts expect that Shire PLC will post $14.78 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Shire PLC (NASDAQ:SHPG) Position Boosted by Hartford Financial Management Inc.” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://stocknewstimes.com/2017/08/01/shire-plc-nasdaqshpg-position-boosted-by-hartford-financial-management-inc.html.
SHPG has been the subject of several recent analyst reports. Royal Bank Of Canada set a $221.00 price target on Shire PLC and gave the company a “buy” rating in a report on Thursday, May 18th. Sanford C. Bernstein reiterated a “market perform” rating and set a $210.00 target price on shares of Shire PLC in a report on Thursday, July 13th. HSBC Holdings plc upgraded Shire PLC from a “reduce” rating to a “hold” rating in a report on Thursday, July 6th. Jefferies Group LLC reiterated a “buy” rating and set a $216.00 target price (down previously from $239.00) on shares of Shire PLC in a report on Friday, June 9th. Finally, Stifel Nicolaus decreased their target price on Shire PLC from $250.00 to $245.00 and set a “buy” rating for the company in a report on Friday, June 9th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and sixteen have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $223.64.
About Shire PLC
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.
